SIGA Technologies declares $0.60 special dividend per share By Investing.com
SIGA Technologies, Inc. (NASDAQ:SIGA) has announced a special cash dividend of $0.60 per share, payable on April 23, 2026, to shareholders of record on April 7, 2026. This dividend matches the previous year's special dividend and reflects the company's strong balance sheet and focus on shareholder value, despite trading near its 52-week low. The company, a commercial-stage pharmaceutical firm, recently reported a Q4 2025 loss but demonstrated overall annual strength with a net income of $23 million and a solid cash balance.
How this was made

The 30-second read
Why it matters
The dividend announcement is a positive signal, potentially boosting investor confidence and stock price in the short term.
Market read
The news is highly relevant for traders and investors holding or considering SIGA Technologies shares, especially those focused on income strategies.
What to watch
Market sentiment may turn negative if upcoming earnings reports reveal continued losses or if broader market conditions deteriorate.
Background
SIGA Technologies is a biotech firm with recent financial challenges but maintains a strong cash position and shareholder-friendly policies.
Ticker impact
The news pertains directly to SIGA Technologies, indicating a potential impact on its stock price.
Moderate increase in stock price around the dividend date, with potential short-term volatility due to dividend payout.
The dividend announcement signals confidence from management and can attract income-focused investors, likely leading to upward price movement in the short term.
Market effects
Potential positive sentiment in the pharmaceutical and biotech sectors due to dividend payout and financial stability.
Limited regional impact; primarily relevant to US-based investors and markets.
Minimal; company-specific news with limited global market implications.
Counterpoint
The recent loss reported in Q4 2025 and trading near 52-week lows may indicate underlying issues that could limit upside potential.
Key entities
- CompanySIGA Technologies
A pharmaceutical company specializing in antiviral and biodefense products.




